CNK
Cinemark Holdings, Inc. NYSE Listed Apr 24, 2007$27.48
Mkt Cap $3.2B
52w Low $21.60
47.4% of range
52w High $34.01
50d MA $28.27
200d MA $26.62
P/E (TTM)
23.4x
EV/EBITDA
11.3x
P/B
7.7x
Debt/Equity
9.3x
ROE
70.9%
P/FCF
15.2x
RSI (14)
—
ATR (14)
—
Beta
1.09
50d MA
$28.27
200d MA
$26.62
Avg Volume
2.3M
Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.
3900 Dallas Parkway · Plano, TX 75093 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | BMO | -0.05 | -0.06 | -20.0% | 29.52 | -1.4% | -6.4% | -7.7% | -8.5% | -6.1% | -6.9% | — |
| Feb 18, 2026 | BMO | 0.24 | 0.16 | -33.3% | 25.36 | -5.7% | +4.1% | +3.9% | +4.5% | +2.1% | +1.2% | — |
| Nov 5, 2025 | BMO | 0.44 | 0.40 | -9.1% | 26.75 | +8.4% | +7.6% | +8.4% | +6.8% | +12.5% | +13.7% | — |
| Aug 1, 2025 | BMO | 0.78 | 0.63 | -19.2% | 26.87 | +5.8% | -3.7% | -4.4% | -5.1% | -7.3% | -7.0% | — |
| May 2, 2025 | BMO | -0.32 | -0.32 | +0.0% | 29.89 | -3.1% | +1.4% | -0.3% | +3.1% | +4.3% | +3.7% | — |
| Feb 19, 2025 | BMO | 0.39 | 0.33 | -15.4% | 33.06 | -5.6% | -13.6% | -15.9% | -17.0% | -18.3% | -19.3% | — |
| Oct 31, 2024 | BMO | 0.56 | 1.19 | +112.5% | 30.48 | -3.7% | -2.4% | -2.1% | -3.0% | -2.6% | +0.9% | — |
| Aug 2, 2024 | BMO | 0.10 | 0.32 | +220.0% | 23.09 | +5.0% | +7.6% | +10.1% | +13.5% | +12.7% | +12.5% | — |
| May 2, 2024 | BMO | -0.20 | 0.19 | +195.0% | 17.43 | +5.0% | +0.9% | +1.7% | -2.4% | -0.3% | -0.3% | — |
| Feb 16, 2024 | BMO | -0.16 | -0.15 | +6.2% | 16.55 | -0.6% | -0.1% | -0.7% | -1.5% | -2.8% | -1.6% | — |
| Nov 3, 2023 | BMO | 0.42 | 0.61 | +45.2% | 16.85 | -0.4% | -2.4% | -9.5% | -8.5% | -11.4% | -12.1% | — |
| Aug 4, 2023 | BMO | 0.55 | 0.80 | +45.5% | 17.32 | +3.9% | +1.2% | +4.3% | +6.0% | +1.2% | +2.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $29.01 | $28.82 | -0.7% | +1.8% | -4.8% | -6.0% | -6.9% | -4.4% |
| Apr 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $29.72 | $29.62 | -0.3% | +3.9% | +2.2% | +2.2% | +2.5% | +0.6% |
| Apr 8 | JP Morgan | Maintains | Overweight → Overweight | — | $29.88 | $30.79 | +3.0% | -0.5% | +3.3% | +1.6% | +1.6% | +1.9% |
| Feb 19 | Barrington Research | Maintains | Outperform → Outperform | — | $26.41 | $26.94 | +2.0% | -0.2% | +0.3% | -1.9% | -2.8% | -1.5% |
| Feb 18 | Macquarie | Maintains | Outperform → Outperform | — | $25.36 | $23.91 | -5.7% | +4.1% | +3.9% | +4.5% | +2.1% | +1.2% |
| Jan 26 | Barrington Research | Maintains | Outperform → Outperform | — | $24.01 | $23.86 | -0.6% | -1.5% | -3.7% | -2.0% | -3.2% | -1.4% |
| Jan 22 | B. Riley Securities | Maintains | Neutral → Neutral | — | $24.18 | $23.81 | -1.5% | -0.2% | -0.7% | -2.2% | -4.4% | -2.7% |
| Jan 22 | JP Morgan | Maintains | Overweight → Overweight | — | $24.18 | $23.81 | -1.5% | -0.2% | -0.7% | -2.2% | -4.4% | -2.7% |
| Jan 15 | Macquarie | Maintains | Outperform → Outperform | — | $24.08 | $24.01 | -0.3% | +1.6% | -0.6% | +2.0% | +0.4% | +0.2% |
| Jan 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $23.09 | $23.28 | +0.8% | +4.3% | +5.9% | +3.6% | +6.3% | +4.7% |
| Dec 18 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $23.49 | $23.02 | -2.0% | -6.6% | -5.2% | -4.4% | -3.3% | -3.4% |
| Nov 6 | JP Morgan | Maintains | Overweight → Overweight | — | $28.79 | $28.79 | +0.0% | +0.7% | -0.7% | +4.5% | +5.6% | +4.3% |
| Oct 21 | Morgan Stanley | Maintains | Overweight → Overweight | — | $26.70 | $26.62 | -0.3% | +2.1% | -1.5% | -1.0% | -1.1% | +1.3% |
| Oct 9 | JP Morgan | Maintains | Overweight → Overweight | — | $25.73 | $25.90 | +0.7% | +3.4% | +0.1% | -2.5% | +1.7% | +4.9% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $28.00 | $28.01 | +0.0% | +3.5% | +2.0% | +1.4% | +2.1% | -1.6% |
| Aug 4 | Barrington Research | Maintains | Outperform → Outperform | — | $25.87 | $25.87 | +0.0% | -0.7% | -1.4% | -3.7% | -3.4% | -4.1% |
| Aug 4 | Roth Capital | Maintains | Buy → Buy | — | $25.87 | $25.87 | +0.0% | -0.7% | -1.4% | -3.7% | -3.4% | -4.1% |
| Aug 4 | Wells Fargo | Maintains | Overweight → Overweight | — | $25.87 | $25.87 | +0.0% | -0.7% | -1.4% | -3.7% | -3.4% | -4.1% |
| Jul 11 | Wedbush | Upgrade | Neutral → Outperform | — | $29.85 | $30.37 | +1.7% | -0.2% | +0.0% | -0.4% | +0.5% | +0.5% |
| Jul 9 | Roth Capital | Maintains | Buy → Buy | — | $30.64 | $30.14 | -1.6% | -6.0% | -2.6% | -2.7% | -2.6% | -3.0% |
| Jul 2 | Benchmark | Maintains | Buy → Buy | — | $30.10 | $30.18 | +0.3% | +0.3% | +2.0% | -0.8% | +1.8% | -4.3% |
| May 5 | JP Morgan | Maintains | Overweight → Overweight | — | $30.30 | $29.31 | -3.3% | -1.7% | +1.7% | +2.9% | +2.3% | +3.1% |
| May 5 | Barrington Research | Maintains | Outperform → Outperform | — | $30.30 | $29.31 | -3.3% | -1.7% | +1.7% | +2.9% | +2.3% | +3.1% |
| Apr 28 | Wedbush | Maintains | Neutral → Neutral | — | $29.54 | $29.73 | +0.6% | +1.6% | +0.8% | +1.3% | +1.2% | +2.6% |
| Apr 11 | JP Morgan | Upgrade | Neutral → Overweight | — | $27.18 | $27.60 | +1.5% | +2.8% | +2.1% | +3.7% | +3.1% | +5.0% |
| Feb 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $28.57 | $28.29 | -1.0% | -2.7% | -3.9% | -5.5% | -6.7% | -9.1% |
| Feb 20 | Macquarie | Maintains | Outperform → Outperform | — | $28.57 | $28.29 | -1.0% | -2.7% | -3.9% | -5.5% | -6.7% | -9.1% |
| Feb 20 | Barrington Research | Maintains | Outperform → Outperform | — | $28.57 | $28.29 | -1.0% | -2.7% | -3.9% | -5.5% | -6.7% | -9.1% |
| Feb 20 | JP Morgan | Maintains | Neutral → Neutral | — | $28.57 | $28.29 | -1.0% | -2.7% | -3.9% | -5.5% | -6.7% | -9.1% |
| Feb 20 | Benchmark | Maintains | Buy → Buy | — | $28.57 | $28.29 | -1.0% | -2.7% | -3.9% | -5.5% | -6.7% | -9.1% |
| Feb 19 | Barrington Research | Maintains | Outperform → Outperform | — | $33.06 | $31.20 | -5.6% | -13.6% | -15.9% | -17.0% | -18.3% | -19.3% |
| Jan 30 | JP Morgan | Maintains | Neutral → Neutral | — | $29.02 | $29.47 | +1.6% | -0.6% | -1.3% | +0.4% | +1.6% | +5.3% |
| Jan 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.83 | $28.66 | -0.6% | +0.7% | +0.1% | -0.7% | +1.1% | +2.2% |
| Jan 10 | Benchmark | Maintains | Buy → Buy | — | $30.43 | $29.82 | -2.0% | -0.9% | -2.2% | -3.5% | -4.5% | -6.1% |
| Dec 18 | Morgan Stanley | Maintains | Overweight → Overweight | — | $31.56 | $31.84 | +0.9% | -2.0% | -0.6% | -2.3% | -3.4% | -2.7% |
| Dec 3 | Benchmark | Maintains | Buy → Buy | — | $36.02 | $35.89 | -0.4% | -1.4% | -1.9% | -1.6% | -2.3% | -7.5% |
| Nov 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $32.84 | $33.75 | +2.8% | +4.1% | +5.1% | +9.7% | +8.1% | +7.6% |
| Nov 4 | Barrington Research | Maintains | Outperform → Outperform | — | $29.85 | $29.88 | +0.1% | -0.9% | -0.5% | +3.0% | +5.8% | +5.6% |
| Nov 1 | Macquarie | Maintains | Outperform → Outperform | — | $29.75 | $29.82 | +0.2% | +0.3% | -0.6% | -0.2% | +3.4% | +6.1% |
| Nov 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $29.75 | $29.82 | +0.2% | +0.3% | -0.6% | -0.2% | +3.4% | +6.1% |
| Nov 1 | Wedbush | Downgrade | Outperform → Neutral | — | $29.75 | $29.82 | +0.2% | +0.3% | -0.6% | -0.2% | +3.4% | +6.1% |
| Oct 31 | Barrington Research | Upgrade | Market Perform → Outperform | — | $30.48 | $29.36 | -3.7% | -2.4% | -2.1% | -3.0% | -2.6% | +0.9% |
| Oct 29 | Wedbush | Maintains | Outperform → Outperform | — | $29.37 | $29.25 | -0.4% | +1.0% | +3.8% | +1.3% | +1.6% | +0.7% |
| Oct 14 | JP Morgan | Maintains | Neutral → Neutral | — | $29.68 | $29.67 | -0.0% | -2.0% | -3.3% | -3.4% | -2.5% | -3.1% |
| Oct 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $28.63 | $29.06 | +1.5% | +3.7% | +1.6% | +0.3% | +0.1% | +1.0% |
| Oct 10 | Roth MKM | Maintains | Buy → Buy | — | $27.35 | $27.55 | +0.7% | +4.7% | +8.5% | +6.4% | +5.0% | +4.8% |
| Oct 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $27.35 | $27.55 | +0.7% | +4.7% | +8.5% | +6.4% | +5.0% | +4.8% |
| Sep 19 | Goldman Sachs | Maintains | Sell → Sell | — | $28.62 | $28.84 | +0.8% | -1.0% | -1.0% | -3.5% | -3.2% | -6.1% |
| Sep 3 | Wedbush | Maintains | Outperform → Outperform | — | $27.38 | $27.45 | +0.3% | -0.5% | +1.3% | +4.4% | +2.6% | +4.5% |
| Aug 28 | Barrington Research | Downgrade | Outperform → Market Perform | — | $28.18 | $27.63 | -2.0% | -1.7% | -1.6% | -2.8% | -3.3% | -1.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Zoradi Mark | — | Sell | 150,000 | $29.52 | $4.4M | 286,608 | -0.95% | — |
Data updated apr 25, 2026 2:12am
· Source: massive.com